...
首页> 外文期刊>Molecular pharmacology. >Probe dependence in the allosteric modulation of a G protein-coupled receptor: Implications for detection and validation of allosteric ligand effects
【24h】

Probe dependence in the allosteric modulation of a G protein-coupled receptor: Implications for detection and validation of allosteric ligand effects

机译:G蛋白偶联受体的变构调节中的探针依赖性:对变构配体效应的检测和验证的意义

获取原文
获取原文并翻译 | 示例
           

摘要

We recently described 3-amino-5-chloro-6-methoxy-4-methylthieno[2,3-b] pyridine-2-carboxylic acid cyclopropylamide (LY2033298) as a novel allosteric modulator of M 4 muscarinic acetylcholine (ACh) receptors (mAChRs) on the basis of its ability to preferentially potentiate the actions of ACh at the M 4 mAChR subtype. In the current study, we show that LY2033298 can also bind to the M 2 mAChR and mediate robust positive or negative allosteric effects, depending on the orthosteric ligand used as a probe of receptor activity. This finding of striking "probe dependence" indicates that the previously described selectivity of the modulator does not arise as a consequence of selective affinity for a poorly conserved allosteric site but rather is due to subtype-selective cooperativity with ACh upon interaction with a common allosteric binding site. Moreover, a comparison of the effects of the modulator on orthosteric ligand affinity relative to signaling through a [ 35S]guanosine 5′-O-(3-thio)triphosphate or extracellular signal-regulated kinase 1/2 phosphorylation assay at the M 2 mAChR revealed that, although the effects on binding were positive in all instances, the effects on signaling were either positive or strongly negative, depending on the agonist and the pathway. Mutational analysis identified residues Tyr177 and Trp99 3.28 (Ballesteros and Weinstein numbers are provided in superscript to indicate relative position of residues within the transmembrane domain) as contributing to the binding of LY2033298, whereas the orthosteric site residues, Tyr104 3.33 and Tyr403 6.51, contributed to the ability of the ligand to impose pathway-biased modulation. Taken together, these findings have important implications for the detection and validation of allosteric modulators of G protein-coupled receptors (GPCRs), because they highlight the potential for ligand misclassification or lack of appreciation of off-target allosteric activities.
机译:我们最近将3-氨基-5-氯-6-甲氧基-4-甲基噻吩并[2,3-b]吡啶-2-羧酸环丙基酰胺(LY2033298)描述为M 4毒蕈碱乙酰胆碱(ACh)受体的新型变构调节剂( mAChRs)基于其优先增强ACh对M 4 mAChR亚型的作用的能力。在当前的研究中,我们表明LY2033298也可以与M 2 mAChR结合并介导强大的正或负变构效应,这取决于用作受体活性探针的正构配体。惊人的“探针依赖性”这一发现表明,上述调节剂的选择性并非由于对保守性较差的变构位点具有选择性亲和力而产生,而是由于与普通变构结合相互作用后与ACh的亚型选择性协同作用现场。此外,在M 2 mAChR上,相对于通过[35S]鸟苷5'-O-(3-硫代)三磷酸或细胞外信号调节激酶1/2磷酸化测定的信号,调节剂对正构配体亲和力的影响比较揭示了尽管对结合的影响在所有情况下均为阳性,但对信号的影响则为阳性或强烈阴性,这取决于激动剂和途径。突变分析确定残基Tyr177和Trp99 3.28(上标提供了Ballesteros和Weinstein号以指示残基在跨膜结构域中的相对位置)有助于LY2033298的结合,而正构位点残基Tyr104 3.33和Tyr403 6.51有助于配体施加通路偏向调节的能力。综上所述,这些发现对于G蛋白偶联受体(GPCR)的变构调节剂的检测和验证具有重要意义,因为它们突出了配体分类错误或脱靶变构活性缺乏认识的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号